Journal
CURRENT STEM CELL REPORTS
Volume 3, Issue 4, Pages 348-357Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s40778-017-0102-8
Keywords
Cancer stem cells; Radiation oncology; Glioblastoma multiforme; Translational oncology
Categories
Funding
- National Institute of Neurological Disorders and Stroke [1R01NS096376-01A1]
- American Cancer Society [RSG-16-034-01-DDC]
Ask authors/readers for more resources
Purpose of Review Radiation became a pillar of oncologic treatment in the last century and provided a powerful and effective locoregional treatment of solid malignancies. After achieving some of the first cures in lymphomas and skin cancers, it assumed a key role in the curative treatment of epithelioid malignancies. Despite success across a variety of histologic types, glioblastoma (GBM), the most common primary brain tumor afflicting adults, remains ultimately resistant to current radiation strategies. While GBMs demonstrate an initial response, recurrence is essentially universal and fatal and typically reoccur in the areas that received the most intense radiation. Recent Findings Glioma stem cells (GSCs), a subpopulation of tumor cells with expression profiles similar to neural stem cells and marked self-renewal capacities, have been shown to drive tumor recurrence and preclude curative radiotherapy. Recent research has shown that these cells have enhanced DNA repair capacity and elevated resistance to cytotoxic ion fluxes and escape multimodality therapies. Summary We will analyze the current understanding of GSCs and radiation by highlighting key discoveries probing their ability to withstand radiotherapy. We then speculate on novel mechanisms by which GSC can be made sensitive to or specifically targeted by radiation therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available